Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.3K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.3K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.8K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

464
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
464
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

784
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
784
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

91
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
91
Pharmacodynamic Models: Emax Drug–Concentration Effect Model01:18

Pharmacodynamic Models: Emax Drug–Concentration Effect Model

187
The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...
187

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV cascade, key indicators, and other epidemiological metrics in Australia (2004-2023): a retrospective analysis.

The Lancet regional health. Western Pacific·2026
Same author

Epidemiology of mpox outbreaks in Australia and insights from epidemic response and surveillance data: a mixed-methods study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study.

Lancet (London, England)·2026
Same author

Capacity and service readiness of facilities for non-communicable diseases in Bangladesh: a health system perspective from two selected districts.

BMC health services research·2026
Same author

Respiratory syncytial virus (RSV) vaccination program for older Australians reduces health inequalities: a distributional cost-effectiveness analysis.

Vaccine·2026
Same author

Estimating the cost-effectiveness of respiratory syncytial virus (RSV) vaccination program for older Australian adults.

Vaccine·2026
Same journal

HIV seroprevalence, incidence, and viral suppression among Ugandan female bar workers: a population-based study.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Evaluating Associations Between Cumulative Use of Chronic Liver Injury-Inducing Antiretroviral Therapy and Hepatocellular Carcinoma, By Chronic Liver Disease Status.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Men's preferences for HIV self-test distribution strategies in Uganda: A discrete choice experiment.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Preferences for HIV testing among partners of transgender women in Lima, Peru: a discrete choice experiment.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Trends in sexually transmitted infections by PrEP use among cisgender men who have sex with men in New York City, 2014-2023.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Birth and Infant Growth Outcomes Following Prenatal Exposure to Bictegravir.

Journal of acquired immune deficiency syndromes (1999)·2026
See all related articles

Related Experiment Video

Updated: Apr 15, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K

Optima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource Optimization.

Cliff C Kerr1, Robyn M Stuart, Richard T Gray

  • 1*The Kirby Institute, University of New South Wales, Sydney, Australia; †School of Physics, University of Sydney, Sydney, Australia; ‡Department of Mathematical Sciences, University of Copenhagen, Copenhagen, Denmark; §Global HIV/AIDS Program, World Bank Group, Washington, DC; ‖Harvard School of Public Health, Harvard University, Boston, MA; ¶The Global Fund, Geneva, Switzerland; and #Sudan National HIV/AIDS Control Programme, Khartoum, Sudan.

Journal of Acquired Immune Deficiency Syndromes (1999)
|March 25, 2015
PubMed
Summary
This summary is machine-generated.

Optima is a software tool for modeling HIV epidemics and interventions. It optimizes resource allocation to meet strategic HIV objectives, aiding policy and program decisions globally.

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.5K
Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.8K

Related Experiment Videos

Last Updated: Apr 15, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.5K
Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.8K

Area of Science:

  • Epidemiology
  • Health Economics
  • Public Health Policy

Background:

  • HIV epidemic modeling requires tools for practical policy and program challenges.
  • Existing models may not fully address resource optimization for strategic HIV objectives.

Purpose of the Study:

  • Introduce Optima, a software package for HIV epidemic and intervention modeling.
  • Highlight Optima's resource optimization capabilities for strategic HIV objectives.
  • Compare Optima with existing HIV models used for funding and coverage decisions.

Main Methods:

  • Optima calibrates to epidemiological data and models program costs, coverage, and outcomes.
  • Users define objectives (e.g., minimize infections, deaths, costs) and Optima determines optimal resource allocation.
  • The model allows flexibility in population groups, programs, data input, and output generation.

Main Results:

  • Optima enables HIV-related financial commitment projections and health economic assessments.
  • It determines optimal resource allocation and program coverage levels to meet user-defined objectives.
  • The software has been utilized in over 20 countries for evidence-based HIV epidemic analyses.

Conclusions:

  • Optima provides a flexible and powerful tool for optimizing HIV interventions and resource allocation.
  • It supports evidence-based decision-making for national strategies, program planning, and investment.
  • There is growing demand for Optima to inform HIV program funding and coverage targets worldwide.